Bms-191095
| Title | Journal |
|---|---|
| The cytoprotective action of the potassium channel opener BMS-191095 in C2C12 myoblasts is related to the modulation of calcium homeostasis. | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101 |
| ROS-independent preconditioning in neurons via activation of mitoK(ATP) channels by BMS-191095. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20080601 |
| GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. | Basic research in cardiology 20070701 |
| Chronic preconditioning: a novel approach for cardiac protection. | American journal of physiology. Heart and circulatory physiology 20070501 |
| The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070201 |
| Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. | American journal of physiology. Heart and circulatory physiology 20060601 |
| Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. | Brain research bulletin 20050730 |
| Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction. | American journal of physiology. Heart and circulatory physiology 20050201 |
| BMS-191095, a cardioselective mitochondrial K(ATP) opener, inhibits human platelet aggregation by opening mitochondrial K(ATP) channels. | Archives of pharmacal research 20050101 |
| Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors. | Journal of medicinal chemistry 20040226 |
| The mitochondrial K(ATP) channel opener BMS-191095 induces neuronal preconditioning. | Neuroreport 20040209 |
| In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects. | The Journal of pharmacology and experimental therapeutics 20021001 |
| Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. | Cardiovascular research 20020815 |
| Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemia. | Cardiovascular drug reviews 20020101 |
| Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity. | The Journal of pharmacology and experimental therapeutics 20010601 |
| Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. | Journal of medicinal chemistry 20010524 |